ANBESOL

This brand name is authorized in Ireland, United Kingdom, South Africa

Active ingredients

The drug ANBESOL contains a combination of these active pharmaceutical ingredients (APIs):

1 Cetylpyridinium UNII D9OM4SK49P - CETYLPYRIDINIUM CHLORIDE

Cetylpyridinium is an antiseptic with activity against both gram positive and gram negative organisms. Read about Cetylpyridinium

2 Chlorocresol UNII 36W53O7109 - CHLOROCRESOL

Chlorocresol has a disinfectant action. Read about Chlorocresol

3 Lidocaine UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. Read about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D04AB	Anesthetics for topical use	D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc.
Discover more medicines within D04AB
N01BB52	Lidocaine, combinations	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 388616, 40135, 40233
Country: ZA	Health Products Regulatory Authority	Identifier(s): J/13.4.2/344